Authors:
Pan, Y
Lui, WO
Nupponen, N
Larsson, C
Isola, J
Visakorpi, T
Bergerheim, USR
Kytola, S
Citation: Y. Pan et al., 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines, GENE CHROM, 30(2), 2001, pp. 187-195
Authors:
Saarenmaa, I
Salminen, T
Geiger, U
Heikkinen, P
Hyvarinen, S
Isola, J
Kataja, V
Kokko, ML
Kokko, R
Kumpulainen, E
Karkkainen, A
Pakkanen, J
Peltonen, P
Piironen, A
Salo, A
Talviala, ML
Hakama, M
Citation: I. Saarenmaa et al., Validity of radiological examinations of patients with breast cancer in different age groups in a population based study, BREAST, 10(1), 2001, pp. 78-81
Authors:
Di Leo, A
Larsimont, D
Gancberg, D
Jarvinen, T
Beauduin, M
Vindevoghel, A
Michel, J
Focan, C
Ries, F
Gobert, P
Closon-Dejardin, MT
Dolci, S
Rouas, G
Paesmans, M
Lobelle, JP
Isola, J
Piccart, MJ
Citation: A. Di Leo et al., HER-2 and topo-isomerase II alpha as predictive markers in a population ofnode-positive breast cancer patients randomly treated with adjuvant CMF orepirubicin plus cyclophosphamide, ANN ONCOL, 12(8), 2001, pp. 1081-1089
Authors:
Saarenmaa, I
Salminen, T
Geiger, U
Heikkinen, P
Hyvarinen, S
Isola, J
Kataja, V
Kokko, ML
Kokko, R
Kumpulainen, E
Karkkainen, A
Pakkanen, J
Peltonen, P
Piironen, A
Salo, A
Talviala, ML
Hakama, M
Citation: I. Saarenmaa et al., The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography, BREAST CANC, 67(2), 2001, pp. 117-123
Authors:
Isola, J
Auvinen, A
Poutiainen, M
Kakkola, L
Jarvinen, TAH
Maattanen, L
Stenman, UH
Tammela, T
Hakama, M
Visakorpi, T
Citation: J. Isola et al., Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer, J UROL, 165(5), 2001, pp. 1569-1573
Authors:
Saarenmaa, I
Salminen, T
Geiger, U
Heikkinen, P
Hyvarinen, S
Isola, J
Kataja, V
Kokko, ML
Kokko, R
Kumpulainen, E
Karkkainen, A
Pakkanen, J
Peltonen, P
Piironen, A
Salo, A
Talviala, ML
Hakama, M
Citation: I. Saarenmaa et al., The visibility of cancer on previous mammograms in retrospective review, CLIN RADIOL, 56(1), 2001, pp. 40-43
Authors:
Rennstam, K
Baldetorp, B
Kytola, S
Tanner, M
Isola, J
Citation: K. Rennstam et al., Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer, CANCER RES, 61(3), 2001, pp. 1214-1219
Citation: M. Tanner et al., Amplification of HER-2/neu and Topoisomerase II alpha in primary and metastatic breast cancer, CANCER RES, 61(14), 2001, pp. 5345-5348
Authors:
Holli, K
Saaristo, R
Isola, J
Joensuu, H
Hakama, M
Citation: K. Holli et al., Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study, BR J CANC, 84(2), 2001, pp. 164-169
Authors:
Kytola, S
Rummukainen, J
Nordgren, A
Karhu, R
Farnebo, F
Isola, J
Larsson, C
Citation: S. Kytola et al., Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping, GENE CHROM, 28(3), 2000, pp. 308-317
Authors:
Miettinen, HE
Jarvinen, TAH
Kellner, U
Kauraniemi, P
Parwaresch, R
Rantala, I
Kalimo, H
Paljarvi, L
Isola, J
Haapasalo, H
Citation: He. Miettinen et al., High topoisomerase II alpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas, NEUROP AP N, 26(6), 2000, pp. 504-512
Citation: Gl. Ferri et al., Direct eye visualization of Cy5 fluorescence for immunocytochemistry and in situ hybridization, J HIST CYTO, 48(3), 2000, pp. 437-444
Authors:
Tanner, M
Gancberg, D
Di Leo, A
Larsimont, D
Rouas, G
Piccart, MJ
Isola, J
Citation: M. Tanner et al., Chromogenic in situ hybridization - A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples, AM J PATH, 157(5), 2000, pp. 1467-1472
Authors:
Jarvinen, TAH
Tanner, M
Rantanen, V
Barlund, M
Borg, A
Grenman, S
Isola, J
Citation: Tah. Jarvinen et al., Amplification and deletion of topoisomerase II alpha associate with ErbB-2amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer, AM J PATH, 156(3), 2000, pp. 839-847
Authors:
Jarvinen, TAH
Pelto-Huikko, M
Holli, K
Isola, J
Citation: Tah. Jarvinen et al., Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer, AM J PATH, 156(1), 2000, pp. 29-35
Authors:
Jarvinen, TAH
Tanner, M
Barlund, M
Borg, A
Isola, J
Citation: Tah. Jarvinen et al., Characterization of topoisomerase II alpha gene amplification and deletionin breast cancer, GENE CHROM, 26(2), 1999, pp. 142-150
Authors:
Persson, K
Pandis, N
Mertens, F
Borg, A
Baldetorp, B
Killander, D
Isola, J
Citation: K. Persson et al., Chromosomal aberrations in breast cancer: A comparison between cytogenetics and comparative genomic hybridization, GENE CHROM, 25(2), 1999, pp. 115-122
Citation: K. Holli et al., Changes in importance of items in the social and personal life of breast cancer patients over time, BREAST, 8(3), 1999, pp. 155-156